Morris Lab
John Carl Morris, MD
John Morris focuses his research and clinical work on Alzheimer’s disease and other age-related neurological disorders. His key areas of interest include:
- Identifying preclinical stages of Alzheimer’s using biomarkers and neuroimaging
- Improving early diagnosis of Alzheimer’s disease
- Studying the relationship between clinical symptoms and brain pathology in dementia
- Testing new drugs for treating dementia
- Defining genetic forms of Alzheimer’s and other dementias
Principal investigator
Recent publications
- Genetic modifiers of APOE-ε4-associated cognitive declineThe Alzheimer’s Disease Neuroimaging Initiative (ADNI), Alzheimer's Disease Genetics Consortium (ADGC) & The Alzheimer's Disease Sequencing Project (ADSP), Dec 2026, In: Nature communications. 17, 1, 2982.Research output: Contribution to journal › Article › peer-review
- Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer diseaseTarawneh, R., Moulder, K. L., Topouza, D. G., Kar, A., Qian, H. T., Pankratz, V. S., Timsina, J., Franklin, E. E., Schindler, S. E., Perrin, R. J., Ances, B. M., Benzinger, T. L. S., Hassenstab, J., Morris, J. C., Holtzman, D. M. & Cruchaga, C., Dec 2026, In: Alzheimer's Research and Therapy. 18, 1, 152.Research output: Contribution to journal › Article › peer-review
- Divergent white matter metabolic signature patterns indicate impending cognitive decline in aging and dementiathe Alzheimer's Disease Neuroimaging Initiative, Dec 2026, In: Nature communications. 17, 1, 4152.Research output: Contribution to journal › Article › peer-review
- Circulating lipids are related to longitudinal changes of ATN biomarkers for Alzheimer’s diseaseAlzheimer’s Disease Neuroimaging Initiative & Alzheimer's Disease Metabolomics Consortium (ADMC), Sep 2026, In: Molecular Psychiatry. 31, 9, p. 5395-5408 14 p.Research output: Contribution to journal › Article › peer-review
- Predicting future cognitive impairment in preclinical Alzheimer’s disease using amyloid PET and MRI: A multisite machine learning studyfor the Alzheimer's Disease Neuroimaging Initiative & for the Preclinical Alzheimer’s Disease Consortium, Sep 2026, In: Neurobiology of Aging. 165, p. 8-23 16 p.Research output: Contribution to journal › Article › peer-review